ESTEVE and UAB advances in their program to develop a cure for sanfilippo a syndrome
ESTEVE has announced the signing of two agreements that will enable it to progress the development of its gene therapeutic for the treatment of Mucopolysaccharidosis type IIIA (MPSIIIA or Sanfilippo A Syndrome) and begin a...
![Esteve i la UAB impulsen el desenvolupament d'un tractament per a la síndrome de Sanfilippo A](/Imatge/129/438/esteve,1.jpg)